期刊文献+

通脉愈心浓缩丸对颈动脉内中膜厚度及血脂的影响 被引量:5

Effect of Tongmaiyuxin Condensed Pill on Tunica Media Thickness of Carotid Artery and Blood Fat
在线阅读 下载PDF
导出
摘要 目的:探讨通脉愈心浓缩丸对颈动脉内中膜厚度(IMT)及血脂的影响。方法:选择颈动脉粥样硬化患者130例随机分为两组,对照组口服阿托伐他汀钙片,治疗组在对照组的基础上加用通脉愈心浓缩丸,1 a为1个疗程。结果:两组IMT及血脂均有明显改善(P<0.01),而且治疗后两组间比较也具有显著性差异(P<0.05)。结论:通脉愈心浓缩丸能较好的降低颈动脉内中膜厚度及改善血脂水平。 Objectives:To study the effects of Tongmaiyuxin condensed pill on intima-media thickness (IMT) of carotid artery and bloodfat. Methods :130 patients of carotid atherosclerosis were divided randomly into treatment group (65 cases) and control group (65 cases). The control group was treated with atorvastatin calcium while the treatment group was addtionally given Tongmaiyuxin condensed pill on the basis of the treatment given to the control group. The course of treatment of two groups was 1 year. Results : Compared with the condition before treatment, both groups had significant improvement on intima-media thickness of carotid artery and blood-fat (P 〈 0.01 ). Improvement on intima-media thickness of carotid artery and blood-fat showed significant difference between the two groups after treatment ( P 〈 0.05 ). Conclusion: Tongmaiyuxin condensed pill can decrease intima-media thickness of carotid artery and improve blood-fat.
出处 《中医学报》 CAS 2012年第12期1651-1652,共2页 Acta Chinese Medicine
基金 郑州市科技攻关计划项目(编号:064SGDS33221-2)
关键词 通脉愈心浓缩丸 颈动脉内中膜厚度 血脂 阿托伐他汀钙片 tongmai yuxin condensed pill intima-media thickness of carotid artery blood-fat atorvastatin calcium
  • 相关文献

参考文献4

  • 1邹艳华 戈晓华.颈部动脉超声多普勒实用手册[M].北京:学苑出版社,1996.6.
  • 2Bots M L,Hoes A W,Koudstaa P,et al.Common carotid intima-media thickness and risk of stroke and myocardial infarction:the Rot-terdam Study[J].Circulation,1997,96(5):1432.
  • 3Salonen J T,Salonen R.Ultrasound B-mode imaging in observationalstudies of atherosclerosis progression[J].Circulation,1993,87(12):1156.
  • 4徐爱建,陈建平,何洪强.辛伐他汀对颈动脉内中膜厚度及CRP的影响[J].浙江医学,2008,30(11):1245-1246. 被引量:6

二级参考文献8

  • 1秦晋梅,李建军.他汀类药物的抗炎作用[J].中国动脉硬化杂志,2004,12(3):363-366. 被引量:43
  • 2Brown B G, Zhao X Q. Importace ofendothelial function in mediating thebenefits of lipidlowering therapy[J]. Am J Cardiol, 1998, 82(10B):49T-52T.
  • 3Grethe S. Tell George Howard, William M, et al. Risk factors for site specific extracranial carotid artery plaque distribution as measured by B-mode ultraso-und[J]. J Clin Epidemiol, 1989, 42:551-559.
  • 4Prisant L M, Zemel P C, Nichols F T, et al. Carotid plaque associations among hypertensive patients[J]. Arch Intern Med, 1993, 153(4):501-506.
  • 5Corti R, Fayad Z A, Fuster V, et al. Effects of lipidlowering by simvastatin on human atherosclerotic lesions [J]. Circulation, 2001, 104(3):249-252.
  • 6Knapp A C, Huang J, Starling G, et al. Inhibitors of HMGCOA reductase sensitize human smooth muscle cells to Fasligand and cytokineinduced cell death [J]. Atherosclerosis, 2000, 152:217- 227.
  • 7Gordon D, Rifkind B M. Currint concepts:high density lipoproteinsthe clinical implications of recent studies[J]. N Engl J Med, 1989, 321:1311-1315.
  • 8林培林,王涛,李雅男,曹广智.阿托伐他汀对高脂血症患者颈动脉内膜中层厚度及凝血系统的影响[J].高血压杂志,2004,12(1):21-23. 被引量:15

共引文献16

同被引文献73

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部